Therapeutic Use Exemptions

Events in the World Archery calendar that include the TUE icon require any athlete taking medication that falls under the prohibited list to have a therapeutic use exemption to compete.

All World Archery record status events require TUE.

What is a TUE?

Athletes may have conditions that require them to take medications that fall under the prohibited list. A therapeutic use exemption may give the athlete authorisation to take the required medicine and still compete without breaking anti-doping rules.

TUE are issued for specific substances and specific usage. Athletes in doubt as to whether they require a TUE should consult the prohibited list, the World Anti-Doping Code, World Archery Anti-Doping Rules and International Standard for Therapeutic Use Exemptions.

Applying for TUE

The International Standard for Therapeutic Use Exemptions ensures the process of granting TUE is the same across sports and nations.

For certain medical conditions (like asthma and ADHD), WADA developed guidelines that should be followed when applying for TUE. Check whether there are guidelines for your condition.

International level athletes – those who are part of the World Archery Registered Testing Pool or compete at world championships – should apply to World Archery for TUE.

National level athletes – those who compete at the sport within their own countries – should contact their National Anti-Doping Organisation to see whether they qualify as requiring a TUE.

If you are unsure as to who to apply to for TUE, pleasecontact us

Competing Internationally with a National TUE

If an athlete has been granted TUE by their National Anti-Doping Organisation then that TUE is automatically valid for international competition provided that TUE has been reported in accordance with the International Standard for Therapeutic Use Exemptions and it is not for beta-blockers.

National athletes with TUE for beta-blockers and wishing to compete at international competition must apply to World Archery for recognition of that TUE.